tiprankstipranks
Advertisement
Advertisement

Generate Biomedicines 25M share IPO priced at $16.00

Goldman Sachs and Morgan Stanley are acting as joint book running managers for the offering. The deal priced at midpoint of $15.00-$17.00 target range.

Meet Samuel – Your Personal Investing Prophet

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1